T1	Participants 247 312	patients with HBe antigen-positive disease acquired in adult life
T2	Participants 404 590	Twenty-one pretreatment variables were assessed for their significance in response prediction using data from 114 patients given alpha-interferon for chronic hepatitis B virus infection.
